Mom is medicine: Implementing maternal-delivered nonpharmacologic care for neonatal opioid withdrawal
妈妈就是药:对新生儿阿片类药物戒断实施产妇非药物护理
基本信息
- 批准号:10448783
- 负责人:
- 金额:$ 16.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAffectAgreementAwardBreast FeedingCOVID-19 pandemicCaringCharacteristicsClinical TreatmentClinical TrialsCollectionComplementComplexConduct Clinical TrialsDataData CollectionData SetDiagnosisEatingEffectivenessEvidence based interventionExpenditureExposure toFutureGoalsHealthHealth Services ResearchHelping to End Addiction Long-termHospital CostsHospital UnitsHospitalizationHospitalsInfantInterventionInterviewInvestmentsKnowledgeLeadershipLengthLength of StayLinkMaternal ExposureMedical RecordsMedicineMentorsMentorshipMethodologyMethodsMothersNational Institute of Child Health and Human DevelopmentNeonatalNeonatal Abstinence SyndromeNeonatal Intensive Care UnitsNewborn InfantNurse&aposs RoleOutcomePerinatalPharmaceutical PreparationsPharmacological TreatmentPilot ProjectsPoliciesPostpartum PeriodPublic HealthRandomized Controlled TrialsRecoveryReportingResearchResearch PersonnelResearch ProposalsRoleScientistSeveritiesSkinSkin CareSleepStructureSurveysTechniquesTestingTrainingUnited States National Institutes of HealthWeaningWithdrawal SymptomWomananalytical methodcare deliverycare outcomescareer developmentcostcost estimatedaltondemographicsdesigndrug withdrawalevidence baseexperiencehigh risk infantimplementation determinantsimplementation effortsimplementation evaluationimplementation facilitatorsimplementation frameworkimplementation outcomesimplementation scienceimplementation strategyimprovedimproved outcomeinnovationlong-term sequelaeneonatal careneonatal outcomenovelopioid epidemicopioid exposureopioid overdoseopioid useopioid withdrawalperinatal healthprogramsrecruitresearch and developmentroutine careskillssubstance usesuccesstheories
项目摘要
PROJECT SUMMARY/ABSTRACT
The long-term goal of this K08 career development proposal is to advance my training in perinatal health
services research with the goal of improving the health of substance-exposed, maternal-infant dyads.
My new skills and experiences will be in 1) management of complex datasets; 2) multilevel and
triangulation analytics; 3) implementation strategy design and testing; and 4) leadership for policy
engagement and impact. The aims of the research proposal seek to improve outcomes of opioid-
exposed infants by improving breastfeeding and skin-to-skin care practices. Nonpharmacologic
approaches are considered primary treatment for opioid-exposed infants. However, many opioid-using women
eligible to breastfeed do not and less than 50% of those who start, stop within six days postpartum. Opioid-
exposed infants are vulnerable to withdrawal symptoms, resulting in longer lengths of hospitalization, exposure
to pharmacologic treatment, and increased hospital costs. It is well-recognized that breastfeeding and skin-to-
skin care can reduce severity and number of neonatal withdrawal symptoms, improve maternal-infant bonding
as well as decrease lengths of stay and reduce costs. Despite these benefits, breastfeeding and skin-to-skin
rates remain remarkably low and it is unclear why they have not been broadly implemented. It may be because
most implementation efforts have focused on clinician activities (e.g., assessment, diagnosis, pharmacologic
treatment) and not on mothers and their care for their newborns. Toward the goal of better understanding the
structural and personal barriers to breastfeeding and skin-to-skin as treatment for opioid-exposed infants, the
proposed 5-year study will examine factors affecting breastfeeding and skin-to-skin practices using a mixed
methods design. Four hospitals have been recruited for collection of medical record data from linked maternal-
infant dyads (N=360), survey data from clinicians (N=513 anticipated) to describe and explore relevant
implementation factors, and longitudinal semi-structured interview data from opioid-exposed mothers (N=30).
Aim 1 scrutinizes the effects of maternal, neonatal, and unit context factors on breastfeeding and skin-to-skin
care to treat opioid-exposed infants using method triangulation and multilevel analytics. Aim 2 detects and
interrogates the implementation facilitators, barriers, and strategies relevant to implementation of maternal-
delivered care using semi-structured interviews with mothers, data triangulation and theory-informed
implementation mapping. Aim 3 conducts a pilot implementation strategy and evaluates implementation and care
delivery outcomes. Completion of these aims provides the requisite training and data for an R01 proposal. This
proposal is synergistic and uniquely complimentary with NICHD’s current investment in addressing neonatal
opioid withdrawal. Formal training is planned under the mentorship of Dr. Vanessa Dalton and co-mentors with
relevant methodologic and content expertise. Training will complement my expertise in implementation science,
address training gaps, and contribute to the success and public health impact of the proposed research.
项目总结/摘要
这个K 08职业发展建议的长期目标是促进我在围产期健康方面的培训
服务研究,目标是改善物质暴露的母婴二人组的健康。
我的新技能和经验将在1)复杂数据集的管理; 2)多层次和
三角分析; 3)实施战略设计和测试;以及4)政策领导
参与和影响。该研究提案的目的是寻求改善阿片类药物的结果,
通过改进母乳喂养和皮肤接触护理做法,减少接触过艾滋病毒/艾滋病的婴儿。非药物
这些方法被认为是接触阿片类药物的婴儿的主要治疗方法。然而,许多使用阿片类药物的妇女
不适合母乳喂养且低于50%者开始,产后6天内停止。阿片类-
暴露的婴儿容易出现戒断症状,导致住院时间延长,暴露
药物治疗,增加了住院费用。众所周知,母乳喂养和皮肤接触
皮肤护理可以减少新生儿戒断症状的严重程度和数量,改善母婴联系
以及缩短停留时间和降低成本。尽管有这些好处,母乳喂养和皮肤接触
比率仍然非常低,不清楚为什么没有广泛执行。可能是因为
大多数实现努力集中在临床医生活动(例如,评估、诊断、药理学
治疗),而不是对母亲及其对新生儿的照顾。为了更好地了解
母乳喂养和皮肤接触作为阿片类药物暴露婴儿治疗的结构和个人障碍,
一项拟议的5年研究将使用混合方法检查影响母乳喂养和皮肤接触的因素。
方法设计本研究共招募了四家医院,收集了与产妇有血缘关系的病历资料,
婴儿二元组(N=360),来自临床医生的调查数据(预期N=513),以描述和探索相关
实施因素,以及来自阿片类药物暴露母亲的纵向半结构化访谈数据(N=30)。
目的1详细研究母亲、新生儿和单位环境因素对母乳喂养和皮肤接触的影响
使用三角测量和多层次分析法治疗阿片类药物暴露的婴儿。Aim 2检测并
询问与实施孕产妇相关的实施促进者、障碍和策略
使用半结构化的母亲访谈,数据三角测量和理论知情
实现映射。目标3开展试点执行战略,并评价执行情况和护理
交付成果。这些目标的完成为R 01提案提供了必要的培训和数据。这
该提案与NICHD目前在解决新生儿疾病方面的投资具有协同作用和独特的互补性。
阿片类药物戒断正式培训计划在Vanessa道尔顿博士的指导下进行,
相关的方法和内容专业知识。培训将补充我在实施科学方面的专业知识,
解决培训差距,并为拟议研究的成功和公共卫生影响做出贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Clayton John Shuman其他文献
Clayton John Shuman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Clayton John Shuman', 18)}}的其他基金
Mom is medicine: Implementing maternal-delivered nonpharmacologic care for neonatal opioid withdrawal
妈妈就是药:对新生儿阿片类药物戒断实施产妇非药物护理
- 批准号:
10653203 - 财政年份:2022
- 资助金额:
$ 16.45万 - 项目类别:
Feasibility of an Art-based Intervention to Address Clinician Stigma and Improve Care for Neonatal Opioid Withdrawal Syndrome
基于艺术的干预措施解决临床医生耻辱并改善新生儿阿片类药物戒断综合症护理的可行性
- 批准号:
10598068 - 财政年份:2022
- 资助金额:
$ 16.45万 - 项目类别:
Feasibility of an Art-based Intervention to Address Clinician Stigma and Improve Care for Neonatal Opioid Withdrawal Syndrome
基于艺术的干预措施解决临床医生耻辱并改善新生儿阿片类药物戒断综合症护理的可行性
- 批准号:
10348928 - 财政年份:2022
- 资助金额:
$ 16.45万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 16.45万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 16.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 16.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 16.45万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 16.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 16.45万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 16.45万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 16.45万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 16.45万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 16.45万 - 项目类别:
Standard Grant














{{item.name}}会员




